+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-12-16Number of Pages: 86

Patient Registry Software Market (By Type - Public Domain Registry Software, Commercial Registry Software; By Disease Areas - Diabetes Registry, Cardiovascular Registry, Cancer Registry, Rare Disease/Orphan Disease Registry, Other Chronic Disease Registry; By End-User - Government, Commercial) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Patient registries are organized systems of data collection for scientific, clinical, or policy purposes. They are the valuable component of randomized controlled trials, used in determining real-world outcomes in the field of medicine. Registries can also be used to evaluate outcomes for various purposes, such as the natural history of a disease, drug or device safety, and the real-world effectiveness of therapies. They can also improve the consistency, quality, and effectiveness of patient care at the point of care. Patient registry software allow individual clinics to carry out quality measurements and comparisons, revealing better opportunities for performance and clinical improvements. With population growth, the prevalence of chronic diseases such as diabetes and cardiovascular diseases has been increasing, resulting in the rise of remote monitoring processes for the management of public health. People have become more aware about chronic diseases and have begun taking accurate and effective treatment for them. Therefore, the adoption of patient registry software for these purposes has increased in a significant manner during the recent years. Various initiatives taken by governments around the globe for improving population health management is another key factor providing a push to the growth of the patient registry software market. 

The need for efficiency and accuracy in patient database management in order to prevent any treatment or therapy error and data loss is further creating the demand for patient registry software. The high costs of clinical trials and other research studies also increases the need for patient registry software. The interoperability issues and patient data privacy and security concerns are considered to be major hindrances to the growth of the patient registry software market. The worldwide lack of healthcare IT professionals also slows down the growth of patient registry software market. The concept of Health 2.0 Social Media in healthcare and cloud-based patient registry software is anticipated to provide a good growth opportunity for patient registry software market in the future. The global patient registry software market generated revenues worth US$ 867.9 Mn in 2014 and is projected to expand at a CAGR of 10.3% during the forecast period (2015 – 2023) to reach US$ 2,077.1 Mn by 2023.

On the basis of type, the patient registry software market is categorized into public domain registry software and commercial registry software. The applications of public domain registry software range from accurate data collection and archiving to data analysis. The growing number of chronic diseases worldwide has led to the increased adoption of public domain registry software, given their simplified architecture and easy operability. On the other hand, commercial registry software is widely adopted by end-users, as they are highly scalable and flexible as compared to public domain registry software.


On the basis of disease areas, the patient registry software market is segmented into diabetes registry, cardiovascular registry, cancer registry, rare disease/orphan disease registry, and other chronic disease registry. Treatment of diabetes in a primary care setting is complex because of the presence of co-morbidities, complications, and the time constraints of the patient interaction. Diabetes registry software keeps track of the population suffering from diabetes, its characteristics, management, and outcomes with or without treatment.

On the basis of end-users, the patient registry software market is segmented into government and commercial segments. Governments have taken various initiatives for disease control and population health management by introducing pilot programs region-wise, which in turn has led to increased adoption of patient registry software. 

patient-registry-software-market


In the coming years, Asia Pacific, Latin America, and Middle East and Africa (MEA) would be the major geographies that would drive the growth of the patient registry software market. In 2014, the key patient registry software vendors included Global Vision Technologies, Inc., Quintiles Inc., Dacima Software Inc., PatientCrossroads, and Evado eClinical Solutions.


Chapter 1 Preface
1.1 Report Description
1.2 Report Scope
1.3 Research Methodology
     1.3.1 Primary Research

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Patient Registry Software Market
2.2 Global Patient Registry Software Market Revenue, 2013 – 2023 (US$ Mn) and Y-o-Y Growth (%)

Chapter 3 Global Patient Registry Software Market Analysis, 2013 – 2023 (US$ Mn)
3.1 Market Dynamics
     3.1.1 Drivers
     3.1.2 Restraints
     3.1.3 Opportunities
3.2 Key Trends Analysis
3.3 Global Patient Registry Software Market Analysis, By Type, 2013 – 2023 (US$ Mn)
     3.3.1 Public Domain Registry Software
     3.3.2 Commercial Registry Software
3.4 Global Patient Registry Software Market Analysis, By Disease Areas, 2013 – 2023 (US$ Mn)
     3.4.1 Diabetes Registry
     3.4.2 Cardiovascular Registry
     3.4.3 Cancer Registry
     3.4.4 Rare Disease/Orphan Disease Registry
     3.4.5 Other Chronic Disease Registry
3.5 Global Patient Registry Software Market Analysis, By End-User, 2013 – 2023 (US$ Mn)
     3.5.1 Government
     3.5.2 Commercial
3.6 Competitive Landscape
     3.6.1 Market Positioning of Key Players, 2014
     3.6.2 Competitive Strategies Adopted by Leading Players

Chapter 4 North America Patient Registry Software Market Analysis, 2013 – 2023 (US$ Mn)
4.1 Key Trends Analysis
4.2 North America Patient Registry Software Market Analysis, By Type, 2013 – 2023 (US$ Mn)
     4.2.1 Public Domain Registry Software
     4.2.2 Commercial Registry Software
4.3 North America Patient Registry Software Market Analysis, By Disease Areas, 2013 – 2023 (US$ Mn)
     4.3.1 Diabetes Registry
     4.3.2 Cardiovascular Registry
     4.3.3 Cancer Registry
     4.3.4 Rare Disease/Orphan Disease Registry
     4.3.5 Other Chronic Disease Registry
4.4 North America Patient Registry Software Market Analysis, By End-User, 2013 – 2023 (US$ Mn)
     4.4.1 Government
     4.4.2 Commercial
4.5 North America Patient Registry Software Market Analysis, By Region, 2013 – 2023 (US$ Mn)
     4.5.1 U.S.
     4.5.2 Rest of North America

Chapter 5 Europe Patient Registry Software Market Analysis, 2013 – 2023 (US$ Mn)
5.1 Key Trends Analysis
5.2 Europe Patient Registry Software Market Analysis, By Type, 2013 – 2023 (US$ Mn)
     5.2.1 Public Domain Registry Software
     5.2.2 Commercial Registry Software
5.3 Europe Patient Registry Software Market Analysis, By Disease Areas, 2013 – 2023 (US$ Mn)
     5.3.1 Diabetes Registry
     5.3.2 Cardiovascular Registry
     5.3.3 Cancer Registry
     5.3.4 Rare Disease/Orphan Disease Registry
     5.3.5 Other Chronic Disease Registry
5.4 Europe Patient Registry Software Market Analysis, By End-User, 2013 – 2023 (US$ Mn)
     5.4.1 Government
     5.4.2 Commercial
5.5 Europe Patient Registry Software Market Analysis, By Region, 2013 – 2023 (US$ Mn)
     5.5.1 EU7
     5.5.2 CIS
     5.5.3 Rest of Europe

Chapter 6 Asia Pacific Patient Registry Software Market Analysis, 2013 – 2023 (US$ Mn)
6.1 Key Trends Analysis
6.2 Asia Pacific Patient Registry Software Market Analysis, By Type, 2013 – 2023 (US$ Mn)
     6.2.1 Public Domain Registry Software
     6.2.2 Commercial Registry Software
6.3 Asia Pacific Patient Registry Software Market Analysis, By Disease Areas, 2013 – 2023 (US$ Mn)
     6.3.1 Diabetes Registry
     6.3.2 Cardiovascular Registry
     6.3.3 Cancer Registry
     6.3.4 Rare Disease/Orphan Disease Registry
     6.3.5 Other Chronic Disease Registry
6.4 Asia Pacific Patient Registry Software Market Analysis, By End-User, 2013 – 2023 (US$ Mn)
     6.4.1 Government
     6.4.2 Commercial
6.5 Asia Pacific Patient Registry Software Market Analysis, By Region, 2013 – 2023 (US$ Mn)
     6.5.1 Japan
     6.5.2 China
     6.5.3 South Asia
     6.5.4 Australasia
     6.5.5 Rest of APAC

Chapter 7 Middle East & Africa (MEA) Patient Registry Software Market Analysis, 2013 – 2023 (US$ Mn)
7.1 Key Trends Analysis
7.2 MEA Patient Registry Software Market Analysis, By Type, 2013 – 2023 (US$ Mn)
     7.2.1 Public Domain Registry Software
     7.2.2 Commercial Registry Software
7.3 MEA Patient Registry Software Market Analysis, By Disease Areas, 2013 – 2023 (US$ Mn)
     7.3.1 Diabetes Registry
     7.3.2 Cardiovascular Registry
     7.3.3 Cancer Registry
     7.3.4 Rare Disease/Orphan Disease Registry
     7.3.5 Other Chronic Disease Registry
7.4 MEA Patient Registry Software Market Analysis, By End-User, 2013 – 2023 (US$ Mn)
     7.4.1 Government
     7.4.2 Commercial
7.5 MEA Patient Registry Software Market Analysis, By Region, 2013 – 2023 (US$ Mn)
     7.5.1 GCC Countries
     7.5.2 North Africa
     7.5.3 South Africa
     7.5.4 Rest of MEA

Chapter 8 Latin America Patient Registry Software Market Analysis, 2013 – 2023 (US$ Mn)
8.1 Key Trends Analysis
8.2 Latin America Patient Registry Software Market Analysis, By Type, 2013 – 2023 (US$ Mn)
     8.2.1 Public Domain Registry Software
     8.2.2 Commercial Registry Software
8.3 Latin America Patient Registry Software Market Analysis, By Disease Areas, 2013 – 2023 (US$ Mn)
     8.3.1 Diabetes Registry
     8.3.2 Cardiovascular Registry
     8.3.3 Cancer Registry
     8.3.4 Rare Disease/Orphan Disease Registry
     8.3.5 Other Chronic Disease Registry
8.4 Latin America Patient Registry Software Market Analysis, By End-User, 2013 – 2023 (US$ Mn)
     8.4.1 Government
     8.4.2 Commercial
8.5 Latin America Patient Registry Software Market Analysis, By Region, 2013 – 2023 (US$ Mn)
     8.5.1 Brazil
     8.5.2 Rest of North America

Chapter 9 Company Profiles
9.1 Global Vision Technologies, Inc.
9.2 Quintiles Inc.
9.3 Dacima Software Inc.
9.4 PatientCrossroads
9.5 Evado eClinical Solutions

This report on the global patient registry software market provides an analysis for the period 2013 – 2023, wherein 2014 is the base year and the period from 2015 to 2023 is the forecast period. Data for 2013 has been included as historical information. The report covers all the prevalent trends and technologies playing a major role in the growth of the patient registry software market over the forecast period. It also highlights various drivers, restraints, and opportunities expected to influence the market growth during the said period. The study provides a holistic perspective on market growth, throughout the above forecast period in terms of revenue estimates (in US$ Mn), across different geographies, which include North America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA), and Latin America (LATAM). 

Patient registries are the computerized databases that contain personal, medical, social, and financial data being reported by healthcare professionals and patients. For rare or chronic diseases, registries can provide vital epidemiological data such as incidence and prevalence, symptoms, and severity of the disease to researchers and healthcare professionals. Due to the continuous growth of chronic diseases, population and disease management is highly needed, which in turn drives the overall demand for patient registry software. The growing demand for patient registry software has led to the emergence of patient registry software vendors around the world, which has contributed to the growth of market size globally. 

This research report provides in-depth analysis of the global patient registry software market on the basis of software types, disease areas, and end-users. The patient registry software types are public domain and commercial. The patient registry software on the basis of disease areas is divided into diabetes registry, cardiovascular registry, cancer registry, rare disease/orphan disease registry, and other chronic disease registry. The patient registry software end-user segment comprises government and commercial segments. 

In terms of geographical regions, the report segments the global patient registry software market into North America, Europe, Asia Pacific, Middle East & Africa (MEA), and Latin America; the regions are analyzed in terms of revenue generation. The report provides cross-sectional analysis of the global patient registry software market in terms of market estimates and forecasts for all segments across different geographic regions. 

The report also includes competitive profiling of major players engaged in developing patient registry software. Major business strategies adopted by them, their market positioning, and various recent developments have also been identified in the research report. This report also provides market share analysis of major players in the patient registry software market based on their 2014 revenues. Some of the major players profiled in the report include Global Vision Technologies, Inc., Quintiles Inc., Dacima Software Inc., PatientCrossroads, and Evado eClinical Solutions.

The global patient registry software market is segmented as below: 

Patient Registry Software Market  

By Type

  • Public Domain Registry Software
  • Commercial Registry Software

By Disease Areas

  • Diabetes Registry
  • Cardiovascular Registry
  • Cancer Registry
  • Rare Disease/Orphan Disease Registry
  • Other Chronic Disease Registry

By End-User

  • Government
  • Commercial

By Geography

  • North America
    • U.S.
    • Rest of North America
  • Europe
    • EU7 Countries
    • CIS Countries
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • South Asia
    • Australasia
    • Rest of APAC
  • Middle East and Africa
    • GCC Countries
    • North Africa
    • South Africa
    • Rest of MEA
  • Latin America
    • Brazil
    • Rest of Latin America